Acute pancreatitis and type 2 diabetes mellitus: who is guilty?
Journal Title: The European Research Journal - Year 2015, Vol 1, Issue 2
Abstract
Many factors play a role in the etiology of acute pancreatitis and its pathogenesis is not fully understood. Dipeptidyl peptidase 4 (DPP-4) inhibitors are a new group of agents for the treatment of Diabetes Mellitus (DM). There are some controversies about specific adverse events such as pancreatitis and hypersensitivity reactions. A 50-year-old morbid obese woman presented with upper abdomen pain after the eating food, nausea and vomiting. She was diagnosed with type 2 diabetes mellitus 7 years ago. Vildagliptin had been added to her treatment six months ago. Abdominal examination revealed epigastric tenderness with guarding. Laboratory data revealed elevated pancreatic enzymes. Abdominal computed tomography (CT) showed features of pancreatitis. Vildagliptin was stopped and patient's symptoms had diminished in parallel with normalization of pancreatic enzymes; and at the 5th day patient was discharged with healthy condition. She was free of symptoms and all laboratory data were normal at the 30th day after discharge. It is important to keep in mind that diabetic patients have an increased risk of pancreatitis which may be related to obesity, hyperlipidemia and/or drugs.
Authors and Affiliations
Ferit Kerim Kucukler, Yasin Simsek, Murat Baglicaklioglu, Gupse Adali, Serdar Guler
Keywords
Related Articles
- EP ID EP195418
- DOI 10.18621/eurj.2015.1.2.74
- Views 142
- Downloads 0
Minimally invasive beating heart full coronary artery bypass in a patient with pancreatic ductal adenocarcinoma
There are various problems associated with cardiopulmonary bypass in cardiac operations of patients with cancer. Our patient was a 73-year-old male patient diagnosed with pancreatic ductal adenocarcinoma. Coronary angiog...
Management of constipation in preventing urinary tract infections in children: a concise review
Objectives: Constipation is a common problem in children. Chronic functional constipation (CFC) has been a claimed conditions that may increase the risk for urinary tract infections (UTIs). Dysfunctional voiding (DV) and...
Hair loss due to aripipirazole use: a case report
Hair loss is one of the side effects that can be seen after medical treatments. Hair loss due to medications is a diffuse state that does not leave scars and usually reversible with stopping the treatment. Aripipirazole...
Rivaroxaban-induced acute pancreatitis
Rivaroxaban is a direct factor Xa inhibitor and has been safely used since 2008. It is used for the detection of atrial fibrillation and venous thromboembolism. Pancreatitis is one of the rare but dangerous side effects...
The incidence and clinical features of meconium aspiration syndrome: a two-year neonatal intensive care experience
Objectives: The aim of this present study was to review the clinical characteristics, risk factors, frequency of meconium aspiration syndrome (MAS), development and maternal demographic characteristics of the newborns bo...